Pfizer’s ambitious $470 million project to expand its Pearl River campus has been postponed until at least the fall.
In a related development, Pfizer laid off 285 employees from its Pearl River campus last December. Pfizer has been a presence in Pearl River since 1907, when Dr. Ernst Lederle developed an antiserum to treat children with diphtheria in New York City. Over the years, the facility has been instrumental in developing several vaccines, including the COVID-19 booster.
Pearl River remains Pfizer’s primary location for global vaccine research and development.
- Advertisement -